NKP-1339

Item no.	DCC-DC9786-250mg
Manufacturer	DCChemicals
CASRN	197723-00-5
Amount	250 mg
Quantity options	100 mg 10 mM x 1 ml in DMSO 1 g 250 mg
Category	Reagents & Chemicals Molecules
Type	Chemicals
Specific against	other
Purity	>98%
Smiles	[Cl-][Ru+3]([N]1=CC2=CC=CC=C2N1)([Cl-])([Cl-])([N]3=CC4=CC=CC=C4N3)[Cl-].[Na+]
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Alias	KP1339,KP 1339,NKP1339,NKP 1339,KP-1339
Similar products	197723-00-5
Available
Manufacturer - Applications	NKP-1339 is the first-in-class ruthenium-based anticancer drug in clinical development against solid cancer and has recently been studied successfully in a phase I clinical trial.
Storage Conditions	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight	502, 14

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 250 mg

available

Delivery expected until 9/25/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer